HIV molecular immunology database

 

Patient Detail

Patient Code 403-006
Patient Sex Male
Risk Factor Sex with male (SM)
Infection Country
Infection City
Infection Year
HLA Type A2, B35, B62
Patient Ethnicity White
Progression
Species human
Patient Note Subject 403-006, 38 years old, who participated in a vaccine trial, acquired HIV within 1,589 days of administration of vaccine vCP205/gp160, 4 times. Response to epitope Gag PPIPVGDIY and Vif DAKLVITTY by EliSpot was 95, and 95 SFU /106 PBMC, 141d post-infection (dpi). [Horton2006a, PMID: 16973582].
CTL CD8+ Records 54929, 54930
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health